Recombinant human nerve growth factor(Chongqing Kerun Biologic)

重组人神经生长因子（重庆科润生物）

Report date: 2026/03/04 20:01:44

Base Information

Drug NameRecombinant human nerve growth factor(Chongqing Kerun Biologic)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsNeurotrophic KeratitisKeratitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
Inactive CompaniesN/A
Active IndicationsNeurotrophic KeratitisKeratitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A